Canadian actress Evangeline Lilly provides a health update after a traumatic brain injury from a fall. She reveals brain scan results showing widespread cognitive decline. Learn her story and the road to recovery.
Actress Evangeline Lilly discloses she sustained brain damage from a hiking fall. The 'Ant-Man' star details her recovery and the incident's impact on her health.
New data shows Eli Lilly's oral weight-loss drug successfully maintains weight reduction after patients switch from injectable medications. A breakthrough for chronic obesity management.
Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.
Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.
An extensive search was conducted in Nova Scotia's Pictou County for siblings Jack and Lilly Sullivan, missing since May 2025. Get the latest details on the investigation.
Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.
Pharmaceutical giant Eli Lilly reports explosive growth driven by Mounjaro and Zepbound, creating intense investor competition and reshaping the obesity treatment landscape.